| Michael Proper, MD | |
|
1 Brace Rd Ste C, Cherry Hill, NJ 08034-2600 | |
| (856) 428-4100 | |
| (856) 428-5748 |
| Full Name | Michael Proper |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1 Brace Rd Ste C, Cherry Hill, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669443313 | NPI | - | NPPES |
| 0879401 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA02823900 (New Jersey) | Primary |
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.
Carefully controlling the amount of food and drink that formerly sedentary, overweight people ingest during and after short-term exercise has a significant impact on insulin action.
› Verified 8 days ago
| Entity Name | Lourdes Cardiology Services, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912202557 PECOS PAC ID: 5799961751 Enrollment ID: O20110510000163 |
News Archive
Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.
Carefully controlling the amount of food and drink that formerly sedentary, overweight people ingest during and after short-term exercise has a significant impact on insulin action.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Proper, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Michael Proper, MD 1 Brace Rd Ste C, Cherry Hill, NJ 08034-2600 Ph: (856) 428-4100 |
News Archive
Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.
Enzon Pharmaceuticals, Inc. today announced its financial results for the first quarter of 2010. During the quarter, the Company completed the sale of its specialty pharmaceutical business. This transaction has now transformed the Company, both financially and operationally, into a biopharmaceutical company dedicated to the discovery and development of oncology medicines.
Brain-related disorders impact almost everyone, either directly or through family or friends. For many of the disorders, whether they're psychiatric or neurological, there are basic scientific descriptions and valuable treatment options, but none has a satisfactory cure because the underlying mechanisms are not fully understood.
Carefully controlling the amount of food and drink that formerly sedentary, overweight people ingest during and after short-term exercise has a significant impact on insulin action.
› Verified 8 days ago
Shagufta Ahsan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 71 Lafayette Ln, Cherry Hill, NJ 08003 Phone: 917-808-5942 | |
Dr. Alexandr Zaslavsky, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2171 Route 70 W, Cherry Hill, NJ 08002 Phone: 856-406-0023 | |
Dr. Tolulope Adesiyun Agunbiade, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Brace Rd Ste C2, Cherry Hill, NJ 08034 Phone: 856-482-8900 | |
Garo Charles Avetian, D.O. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1919 Greentree Rd, Suite A, Cherry Hill, NJ 08003 Phone: 856-761-8100 Fax: 856-761-8107 | |
Matthew Everwine, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2201 Chapel Ave W, Cherry Hill, NJ 08002 Phone: 856-513-4124 | |
Dr. Behjath Jafry, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1210 Brace Rd, Suite 102, Cherry Hill, NJ 08034 Phone: 856-428-6616 Fax: 856-428-4823 | |
William C Groh, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1400 Route 70 East, Cherry Hill, NJ 08034 Phone: 856-216-0300 |